Very early researchStudy completedNCT03842800What this trial is testingCharacterizing Clinical and Pharmacological Neuroimaging BiomarkersWho this might be right forCognitive Impairment Yale University 143
Early research (Phase 1)Looking for participantsNCT07084129What this trial is testingVancomycin and Acute Kidney Injury in Sepsis Treatment - InterventionWho this might be right forSepsis Children's Hospital of Philadelphia 20
Not applicableStudy completedNCT03451734What this trial is testingOptimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic PatientsWho this might be right forSchizophreniaMetabolic Syndrome Central South University 2,000
Not applicableUnknownNCT02803346What this trial is testingEvaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)Who this might be right forImmunology of Septic Shock Hospices Civils de Lyon 160
Not applicableLooking for participantsNCT07251296What this trial is testingImpact of Funcional Exercise and Supplementation in Perimenopausal Women's HealthWho this might be right forPerimenopauseAging University of Valencia 90
Not applicableStudy completedNCT01194336What this trial is testingEvaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human PerformanceWho this might be right forBiomarkers, Pharmacological U.S. Army Medical Research and Development Command 84
Very early researchStudy completedNCT03589898What this trial is testingStudy of Neuroimaging Biomarkers of Social Cognition Deficits in Adolescents (Age 13-17) With Autism Spectrum Disorder and Effects of GabapentinWho this might be right forAutism Spectrum Disorder University of Massachusetts, Worcester 19
Not applicableLooking for participantsNCT04067674What this trial is testingSeptic Shock-induced ImmunosuppressionWho this might be right forSeptic Shock Hospices Civils de Lyon 305
Testing effectiveness (Phase 2)Study completedNCT00278083What this trial is testingTNF-alpha Directed Therapy in AsthmaWho this might be right forAsthma Imperial College London 40
Not applicableStudy completedNCT01166763What this trial is testingModulation of Breast Cancer Risk Biomarkers by High Dose Vitamin DWho this might be right forBreast Cancer Carol Fabian, MD 30
Testing effectiveness (Phase 2)Ended earlyNCT01215565What this trial is testingStudy of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar CarcinomaWho this might be right forHepatocellular CarcinomaFibrolamellar Hepatocellular Carcinoma Assistance Publique - Hôpitaux de Paris 4
Post-approval studies (Phase 4)Study completedNCT01743560What this trial is testingAn Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker AnalysisWho this might be right forOestrogen Receptor Positive Advanced Breast Cancer Novartis Pharmaceuticals 52
Testing effectiveness (Phase 2)Looking for participantsNCT06511908What this trial is testingInvestigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant DepressionWho this might be right forSuicideDepressive Disorder, Treatment-ResistantKetamine+10 more National Institute of Mental Health (NIMH) 50
Not applicableLooking for participantsNCT06462196What this trial is testingNatural History of Depression, Bipolar Disorder and Suicide RiskWho this might be right forBehavioral SymptomsSuicideSelf-Injurious Behavior+18 more National Institute of Mental Health (NIMH) 500
Testing effectiveness (Phase 2)Ended earlyNCT01215578What this trial is testingPredictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine TumorsWho this might be right forNeuroendocrine TumorsPancreatic NeoplasmsAdvanced Disease+1 more Assistance Publique - Hôpitaux de Paris 33
Not applicableStudy completedNCT01339975What this trial is testingLevel of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaWho this might be right forCarcinomaCarcinoma Renal CellKidney Neoplasms+2 more University Hospital, Bordeaux 310
Not applicableStudy completedNCT02152553What this trial is testingBiomarker(s) for GlucocorticoidsWho this might be right forAddison Disease Vastra Gotaland Region 11
Not applicableStudy completedNCT04971590What this trial is testingStudy to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus NephritisWho this might be right forSystemic Lupus Erythematosus GlaxoSmithKline 193
Not applicableLooking for participantsNCT07324330What this trial is testingSlowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical ActivityWho this might be right forParkinson DiseaseProdromal StageNeurodegenerative Diseases+7 more University Hospital, Bonn 130
Early research (Phase 1)Study completedNCT02419560What this trial is testingOptimal Dose Finding Study ABT-199 and Ibrutinib in MCLWho this might be right forLymphoma, Mantle-CellRecurrent Lymphoma, Mantle-Cell Craig Portell, MD 37